These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11747341)

  • 1. Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice.
    Balsari A; Rumio C; Morelli D; Sfondrini L; Nardini E; Barajon I; Ménard S
    Br J Cancer; 2001 Dec; 85(12):1964-7. PubMed ID: 11747341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.
    Morelli D; Ménard S; Colnaghi MI; Balsari A
    Cancer Res; 1996 May; 56(9):2082-5. PubMed ID: 8616854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
    J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
    Takahashi H; Adachi K; Yamaguchi F; Teramoto A
    Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
    Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of mucositis from cytotoxic chemotherapy].
    Amadio P; Ferraù F; Priolo D; Toscano G; Colina P; Mare M; Zavettieri M; La Torre F; Mesiti M; Maisano R
    Clin Ter; 2002; 153(2):127-34. PubMed ID: 12078338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice.
    Zhang XY; Li WG; Wu YJ; Gao MT
    J Pharm Pharmacol; 2005 Aug; 57(8):1043-52. PubMed ID: 16102261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new monoclonal antibody recognizing anthracyclinic molecule.
    Balsari A; Morelli D; Menard S; Tagliabue E; Colnaghi MI; Ghione M
    Anticancer Res; 1990; 10(1):129-32. PubMed ID: 1692196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide prevents doxorubicin-induced apoptosis in RAW 264.7 macrophage cells by inhibiting p53 activation.
    Hassan F; Islam S; Mu MM; Ito H; Koide N; Mori I; Yoshida T; Yokochi T
    Mol Cancer Res; 2005 Jul; 3(7):373-9. PubMed ID: 16046548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients.
    Sung L; Tomlinson GA; Greenberg ML; Koren G; Judd P; Ota S; Feldman BM
    Eur J Cancer; 2007 May; 43(8):1269-75. PubMed ID: 17383174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adriamycin enhances anti-human DR5 monoclonal antibody (mDRA-6) induced HL-60 cells apoptosis].
    Li SL; Ma YF; Liu GC; Zhang J; Bai HL; Liu YJ; Lu F
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):461-4. PubMed ID: 17147249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
    Morelli D; Ménard S; Pozzi B; Balsari A; Colnaghi MI
    Cell Biophys; 1994; 24-25():119-26. PubMed ID: 7736515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.
    Sardini A; Villa E; Morelli D; Ghione M; Ménard S; Colnaghi MI; Balsari A
    Int J Cancer; 1992 Feb; 50(4):617-20. PubMed ID: 1537626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Palifermin can prevent severe oral mucositis during chemotherapy.
    Ann Intern Med; 2010 Sep; 153(6):I-44. PubMed ID: 20855786
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.